Targeting neuroinflammation induced by senescent cells in Parkinson’s Disease to improve outcomes. Biomedical Sciences Innovation Fund, Stony Brook University (SBU) Office of the Vice President for Research (OVPR), (07/23-06/25) $100,000 (direct funds only) PI: Markus Riessland, PhD. Role: Co-Investigator. The aim of this study is to investigate the role of targeting senescent cell-induced inflammation in Parkinson’s Disease for the first time in parallel preclinical and clinical models.
Pilot feasibility study probing the role of the microbiome as a mechanism of mediating signaling along the gut-brain axis in major depressive disorder. SBU OVPR, (04/23-04/24) $65,000 (direct) PI: Olga Aroniadis, MD, MSc, FACG. Role: Co-Investigator. The major goal of this proposal is to understand the effects of celecoxib on microbial and metabolomics profiling in individuals with major depressive disorder.
Stony Brook University evaluation of sleep, depression, fatigue among Stony Brook students. SBU OVPR, (08/22-02/24) $60,000 (direct) PI: Russell Rozensky, MS, RT, RRT-SDS, CPFT, RPSGT, CCSH. Role: Co-Investigator. This proposal focuses on sleep disorders, depression, and anxiety in college students.